Understanding the phenotypic contribution of epigenetic components is making DNA methylation pattern analysis more important in higher eukaryotic genomes as well as human disease. Bisulfite sequencing protocols report DNA methylation occupancy information as a positive assay output that allows methylation patterns to be elucidated from particular developmental or disease states. Reported here is a new method for bisulfite sequencing project management, data analysis, and site-specific methylation test development that is designed for integration in high-throughput genomic and bioinformatics analyses.
The phenotypic consequences of epigenetic alterations are being appreciated in nearly every biological system. In higher eukaryotes, DNA methylation patterns serve as a second genomic information code, an easily monitored proximate marker reflecting epigenetic cellular decisions. Most notably, in human cancer, abnormal cellular DNA methylation patterns can directly contribute to the mechanisms of tumorigenesis, most often through the induction of erroneous gene silencing (1) . Recent work by many groups has demonstrated that DNA methylation abnormalities may be exploited for the development of powerful cancer diagnostic and prognostic tools (2) .
One tool in the arsenal of methylation monitoring is bisulfite sequencing (3) . Bisulfite treatment of DNA causes the deamination of cytosine and conversion to thymine upon amplification and cloning. However, if the cytosine is methylated, it remains unchanged. In this way, subsequent sequencing of the amplified, mutagenized clones with conventional technology allows one to understand the methylation occupancy at each cytosine.
Several groups have released publicly available tools for bisulfite sequencing experimental design or data analysis (4-7). Furthermore, online tools such as methBLAST (medgen.ugent.be/ methblast) have become available for in silico bisulfite modification to aid in PCR primer design. However, the utility is limited in that they either only help with experimental design or with data analysis (i.e., pattern elucidation). For those that offer methylation pattern elucidation, they also require the experimenter to employ a locus-bylocus, one-gene-at-a-time approach. Given the revolution in automated sequencing and the capacity available at most genome centers, a combined design and analysis suite that affords investigators the opportunity to take advantage of a high-throughput, loweffort analysis procedure is missing. Most researchers frustratingly address this unmet need by performing each outlined step in the most labor-intensive but readily apparent manner. Typically, this involves a stepwise approach for each target, often aligning trace files by hand and manually performing the occupancy calculations. Moreover, as multiple-locus biomarkers are discovered and employed, validation of methylation patterns in a multilocus manner from many samples will be necessary. Having an automated analysis capacity will become an even more pressing need.
We have created an efficient package of PERL programs called Figure 1 ). Primer sequences for the analysis shown in Figure 1 are 5′-TGATTTGG GTAAGATTTTGGTTGTGAGTAG-3′ (forward) and 5′-CATCCCTAATAA ACAAAACATAAAACT-3′ (reverse). Bisulfite conversion was performed with the EZ DNA Methylation Kit™ (Zymo Research, Orange, CA, USA) under the manufacturer's recommended conditions. PCR amplification was performed under standard conditions that employed 0.2 pmol of primers, 40 ng of template in a 25-μL volume of water, to which 25 μL of FailSafe™ G 2× premix and 1 U of FailSafe Taq DNA Polymerase (EPICENTRE, Madison, WI, USA) were added. The cycling conditions employed a single 3-min incubation at 95°C, followed by 30 cycles of 95°C for 45 s, 52°C for 15 s, and 72°C for 30 s. Finally, a 10-min chase step was performed by incubating the sample at 72°C. The PCR product was purified from an agarose gel slice and cloned using the pCR2.1-TOPO TA Cloning ® Kit (Invitrogen, Carlsbad, CA, USA). Twenty-four independent clones were prepared and sequenced.
The process starts with bisulfite_ convert.pl, which performs an in silico conversion of the target DNA sequence ( Figure 1A ). Methylatable Cs [i.e., those Cs followed by G (CpG)] are converted to N, and other Cs (nonCpG) are converted either to a T or a Y, depending on the options given. Additionally, there is an option to convert Cs in the C-X-G context (where X is any nucleotide). This is appropriate for analysis of plant genomic DNA, which often methylates Cs in the C-X-G context. The conversion is completed for the sequence and its complement, each as an independent fasta file ( Figure 1 , B and C). Hereafter, the converted sequences are referred to as cTN and cYN, respectively. Primers are then designed from the cTN-converted templates using primer3 (8) or other primer software (e.g., Lasergene ® package, Primerselect module; DNAStar, Madison, WI, USA).
Use of these in silico-converted templates simplifies the design of bisulfite sequencing primers because primer selection constraints can be set so that regions including an N (i.e., a potential site of cytosine methylation) are automatically excluded from consideration. This is a necessary step in order to avoid selective amplification of methylated or unmeth- The bisulfite conversion and sequencing are then performed in the laboratory. Determination of the degree of methylation of a particular cytosine may be made either by directly sequencing the PCR product amplified from the bisulfite-modified DNA or by cloning the PCR product, selecting a number of independent colonies, and independently sequencing each clone. The former approach provides a quick analysis that can provide relative representations of cytosine versus 5-methylcytosine by comparing chromatogram peak levels at each investigated potential methylation site within the amplified product. However, by separately assaying numerous independent molecules, the latter approach provides a more stringent calculation of methylated versus unmethylated states and allows the investigator to identify potential specific methylation pattern populations within the tested DNA sample. For example, a result of directly sequencing the PCR product could be that each CpG dinucleotide was sequenced as C 50% of the time and as T 50% of the time. This could be interpreted as either random 50% methylation of cytosines across the entire population or as two distinct DNA methylation populations; one with 100% methylation and one with no methylation. The distinction between these two possibilities is likely critical for appropriate interpretation of bisulfite sequencing experiments. MethylMapper reduces the time and effort that must be invested in the analysis of independent bisulfitesequenced clones, allowing investigators to take advantage of the benefits of independent clone sequencing projects without having to deal with the added burden of data analysis.
Analysis of the resulting sequences is accomplished by a BLASTN (9) comparison of the converted template sequence as a query with the bisulfite products as a database. Multilocus analysis is accomplished using a library of in silico-converted query sequences that are compared against the entirety of sequencing products obtained. The BLASTN parameters (-p blastn -m 1 -e 1e-20 -F ′mD′) are tuned to allow only the correct products to align with their targets and to enable a multiple sequence display (Figure 1, B and C) . A simple script (cleanBlast.pl) can then be used to clean up the multiplealignment BLAST file by removing individual reports with no hits, which will occur when using the package in a multilocus application.
The multiple sequence output allows the rapid scanning of the sequences to assess conversion efficiency and allows the easy cataloging of C versus T content via a final PERL script (Count_ Bisulfite.pl). The output from Count_ Bisulfite.pl can be exported as a text file for each locus ( Figure 1D ) and into a format that can be used to generate graphical visualizations using a spreadsheet program such as Microsoft ® Excel or OpenOffice.org Calc ( Figure  1E ). The same BLAST analysis can be employed using the cYN fasta files as the query sequence ( Figure 1C) . Analysis of these results allows for the rapid identification of incomplete conversion products by distinguishing nucleotides in the template that were originally Ts versus those that were part of the in silico conversion. Incomplete conversion is seen by the alignment of a template Y to a C in the product instead of a T. Figure 1C shows an example of a poorly bisulfite-converted clone that would introduce unreliable measurements of cytosine methylation.
There are many advantages of using a BLASTN-based analysis process over the previously described ClustalW analyses (5) . First, the appropriateness of ClustalW-based analyses, which attempt to infer an allelic methylation "history" of the locus, appears to be in conflict with molecular data that demonstrate that methylation patterns are not strictly clonal (10, 11) . Second, BLAST-based analyses allow the output to self-organize. Reads from different templates are automatically assembled back onto their digitally converted templates by the process. Theoretically, every well in a 384-well sequencing plate on an ABI Prism ® 3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA) could be from a different genomic location and all can be easily and automatically aligned to the correct template. ClustalW, by default, attempts to align all sequences, forcing each different genomic locus to be analyzed individually. Third, the output BLASTN report format allows for easy visualization of the multilocus data in a familiar intuitive format. Fourth, methylated base calls are easily discriminated from sequencing errors, and sequences of poor quality are eliminated from consideration by adjusting the E-value parameter (-e). Finally, completeness of the conversion reaction can be quality controlled from an empirical quantitative basis rather than a qualitative basis (i.e., reads with Cs that are maintained at non-CG positions and/or CNG can be eliminated from consideration unless every read has the C at that position).
An additional advantage of this strategy is that two in silico-converted templates are utilized that distinguish potentially methylated cytosines from cytosines that are not substrates for DNA methylation. The separate, but complimentary, use of both in silicoconverted query sequences (cTN and cYN) allows the user to effectively address different questions that are critical for the interpretation of bisulfite sequencing results. For example, many bisulfite sequencing projects require the analysis of many independent samples. These samples may differ biologically (i.e., differential DNA methylation occupancies between samples) as well as technically (i.e., differential efficiencies in chemical conversion between samples). Consistency of chemical conversion can be confirmed by aligning a small number of sequencing reaction results obtained from many independent clinical samples with the cYN substituted query sequence. This allows for the efficient identification and subsequent exclusion of samples that underwent inconsistent bisulfite conversion, thus avoiding the unnecessary labor and expense of large-scale analyses of samples that would otherwise introduce potentially misleading results. Quality-controlled samples can then each be analyzed by the sequencing of large numbers of clones. These results are individually aligned and compared with the cTNsubstituted query sequences, allowing easy visualization of results, accurate calculations of DNA methylation occupancy, and production of DNA methylation density maps as described above.
Based upon the analysis of each locale's methylation occupancy, investigators can reenter the primerdesign phase to accelerate specific test development now that the disease-specific pattern of local methylation has been elucidated. These technologies typically employ sitespecific methylation pattern-detecting technologies such as methylationspecific PCR (MSP) (12) , combined bisulfite restriction analysis (COBRA) (13) , and MethyLight analysis (14) , or nonbisulfite-based methylation density-determining technologies such as MethylScreen (15) . The choice of detection technology allows for either the digitally mutagenized template to be used (with the relevant methylation pattern substituted for the Ns and/or Ys) for bisulfite-based technologies, or the native sequence, narrowed to focus the assay in the relevant region.
The strategy outlined in this report allows the laborious process of bisulfite sequence analysis to be simplified to a process applicable to high-throughput, multilocus identification and rapidly transitions the analysis toward detection of clinically relevant DNA methylation events.
